tiprankstipranks
Innate Pharma SA (DE:IDD)
FRANKFURT:IDD
Germany Market
IDD
Innate Pharma SA
RESEARCH TOOLSreports

Innate Pharma SA (IDD) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

IDD Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Innate
Pharma SA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IDD Stock 12 Month Forecast

There Are No Analyst Ratings for DE:IDD In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IDD Financial Forecast

IDD Earnings Forecast

Next quarter’s earnings estimate for IDD is -€0.17 with a range of -€0.28 to -€0.07. The previous quarter’s EPS was -€0.31. IDD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IDD has Performed in-line its overall industry.
Next quarter’s earnings estimate for IDD is -€0.17 with a range of -€0.28 to -€0.07. The previous quarter’s EPS was -€0.31. IDD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IDD has Performed in-line its overall industry.

IDD Sales Forecast

Next quarter’s sales forecast for IDD is €6.43M with a range of €4.86M to €8.00M. The previous quarter’s sales results were €1.12M. IDD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IDD has Performed in-line its overall industry.
Next quarter’s sales forecast for IDD is €6.43M with a range of €4.86M to €8.00M. The previous quarter’s sales results were €1.12M. IDD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IDD has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on DE:IDD
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
€2.49→€2.23
Hold
15.54%
Upside
Reiterated
10/07/25
Goldman Sachs Sticks to Their Hold Rating for Innate Pharma SA (IPHYF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on DE:IDD
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
€2.49→€2.23
Hold
15.54%
Upside
Reiterated
10/07/25
Goldman Sachs Sticks to Their Hold Rating for Innate Pharma SA (IPHYF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

IDD Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
0
0
0
In the current month, IDD has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IDD average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

IDD Stock Forecast FAQ

What is DE:IDD’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:IDD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:IDD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Innate Pharma SA a Buy, Sell or Hold?
      Currently, no data Available
      What is Innate Pharma SA’s share price target?
      Currently, no data Available
      What do analysts say about Innate Pharma SA?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Innate Pharma SA?
      To buy shares of DE:IDD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.